NIGMS announces the transition of pharmacogenomics research from set-aside funding to regular competition. The FOA for Research Centers for Pharmacogenomics in Precision Medicine (P50) is discontinued for 2015 and 2016. Starting in mid-July, any investigator interested in PGx can join the Pharmacogenomics Research Network through the PGRN website.
No comments:
Post a Comment